Patents by Inventor Richard John BUICK

Richard John BUICK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Humanized antibodies targeting human tissue factor
    Patent number: 11401345
    Abstract: The present disclosure provides humanized antibodies and antibody-drug conjugates that specifically bind to human tissue factor, and which do not inhibit tissue factor mediated blood coagulation compared to a normal plasma control. Further described are methods of making and methods of using the disclosed humanized antibodies and antibody-drug conjugates in the treatment of cancer.
    Type: Grant
    Filed: November 26, 2018
    Date of Patent: August 2, 2022
    Assignee: Purdue Pharma L.P.
    Inventors: Daniel A. Soltis, Thomas Mehrling, Richard John Buick
  • HUMANIZED ANTIBODIES TARGETING HUMAN TISSUE FACTOR
    Publication number: 20200385487
    Abstract: The present disclosure provides humanized antibodies and antibody-drug conjugates that specifically bind to human tissue factor, and which do not inhibit tissue factor mediated blood coagulation compared to a normal plasma control. Further described are methods of making and methods of using the disclosed humanized antibodies and antibody-drug conjugates in the treatment of cancer.
    Type: Application
    Filed: November 26, 2018
    Publication date: December 10, 2020
    Applicant: Purdue Pharma L.P.
    Inventors: Daniel A. SOLTIS, Thomas MEHRLING, Richard John BUICK